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The inﬂammasome is an important innate immune pathway that regulates at least two host
responses protective against infections: (1) secretion of the proinﬂammatory cytokines IL-1β and
IL-18 and (2) induction of pyroptosis, a form of cell death. Inﬂammasomes, of which different
types have been identiﬁed, are multiprotein complexes containing pattern recognition receptors
belonging to the Nod-like receptor family or the PYHIN family and the protease caspase-1. The
molecular aspects involved in the activation of different inﬂammasomes by various pathogens are
being rapidly elucidated, and their role during infections is being characterized. Production of IL-1β
and IL-18 and induction of pyroptosis of the infected cell have been shown to be protective against
many infectious agents. Here, we review the recent literature concerning inﬂammasome activation
in the context of bacterial infections and identify important questions to be answered in the future.
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1. INFLAMMASOMES: STRUCTURE AND FUNCTION
The ability to detect infection by pathogenic microbes and to restrict their growth is fundamental for
the well-being of multicellular organisms. Microbial products and endogenous “danger signals” released
by infected or otherwise stressed host cells are recognized by families of pattern recognition receptors
(PRR) resulting in the activation of signaling pathways that initiate the inﬂammatory response and
regulate development of adaptive immunity. Identiﬁcation and characterization of PRR has progressed
very rapidly in the last few years, and their role in the innate immune response to infection continues
to be unraveled. Toll-like receptor (TLR) and C-type lectins are PRR expressed on the cell surface or
in endosomal compartments, while RIG-I-like receptor (RLR) are located in the cytosol (reviewed in
[1]). Stimulation of these receptors results in activation of the NF-κB-, MAPK-, Syk-, and IRF-signaling
pathways culminating in transcriptional induction and the secretion of a large number of cytokines,
chemokines, and immunomodulatory factors. The Nod-like receptors (NLR) family is another group of
cytoplasmic PRR that performs diverse immunological functions (reviewed in [2]). A subgroup of NLR
surveys the cytoplasm for evidence of danger or infection and control activation of the inﬂammasome, a
multiprotein complex that regulates activation of the cysteine protease caspase-1. Activation of caspase-1
in the context of the inﬂammasome is responsible for the proteolytic processing of the immature forms of
Interleukin-1β (IL-1β) and IL-18, two very powerful proinﬂammatory cytokines with pleiotropic activities
[3]. While the production of most proinﬂammatory cytokines is primarily regulated at the transcriptional
level, secretion of IL-1β and IL-18 requires this additional proteolytic step. Thus, IL-1β and IL-18 secretion
is regulated in a two-step fashion. First, stimulation through TLR or RLR induces their synthesis as
inactive precursors that lack signal peptide. Second, NLR-mediated inﬂammasome activation catalyzes
the posttranslational processing that is required for their secretion and bioactivity. It should be noted that
although IL-1β and IL-18 processing is catalyzed most efﬁciently by caspase-1, other proteases can process
IL-1β under particular circumstances, like during high neutrophilic inﬂammation [4–6].
InadditiontoregulatingprocessingandthesecretionofIL-1β andIL-18,inﬂammasomesalsotrigger
pyroptosis, a form of cell death of the infected cell that is distinct from classical apoptosis or necrosis [7].
Pyroptosis, by destroying the pool of infected cells, effectively restricts intracellular bacteria growth and
dissemination and, therefore, is an efﬁcient effector mechanism to protect the host from infection [8, 9].
Af e wi n ﬂammasomes have been recently characterized, and it is likely that many more will soon be
reported. The Inﬂammasomes so far characterized are generally composed of a PRR, the adaptor molecule
ASC, and caspase-1(see model in Figure 1). There is evidencethat other inﬂammatory caspasesmay be part
of inﬂammasomes [10]. At least two families of PRR have been shown to form inﬂammasomes, the NLR
and the PYHIN proteins (Pyrin and HIN200 domain-containing proteins; also known as p200 or HIN200
proteins). Members of both families have a modular domain structure. NLR are characterized by a carboxy-
terminal domain that contains leucine-rich repeats and that likely mediates the interaction with the ligands,
a central nucleotide-binding domain that mediates oligomerization of the receptors, and an amino-terminal
domain that contains either the Pyrin sequence (PYD) or the caspase activation and recruitment domain
(CARD). The PYHIN family is composed of members that have varied functions [11]. PYHIN proteins are
characterized by a carboxy-terminal HIN domain that is able to interact with DNA and an amino-terminal
PYD domain.
Assembly of functional inﬂammasomes is believed to be driven by homophilic interaction between
the PYD and CARD domains of the NLR/PYHIN receptors and the PYD and CARD domains of the adaptor
molecule ASC and the CARD of caspase-1. Assembly of this multiprotein platform, which is reminiscent
of the apoptosome, leads to activation of caspase-1 by the proximity model [12].
NLRP3 and NLRC4 are the best-characterized NLR molecules. The NLRP3 inﬂammasome is the
most studied, and yet, the logic that oversees its activation remains elusive. NLRP3 contains a PYD
domain that mediates the interaction with ASC that, acting as a bridge, recruits caspase-1. The NLRP3
inﬂammasome is activated by a wide variety of particles, crystals, bacterial toxins, as well as viruses
bacteria, and fungi. Because of the great variability in structure and composition of the particles and stimuli























reported to activate the NLRP3 inﬂammasome, their direct interaction with NLRP3 seems unlikely. Rather,
a more probable scenario is that NLRP3 is activated by an endogenous molecule that is generated/modiﬁed
as result of the interaction of the particle/pathogen with the cell. It is possible that more than one type of
NLRP3endogenousactivatorexistsandthatdifferentNLRP3activatorsmayusedistinctsignalingpathways
to generate the same endogenous activator.
An essential requirement for NLRP3 inﬂammasome activation is the uptake of the particle through
phagocytosis, as demonstrated by the fact that cytochalasins or other drugs that inhibit this process also
prevent pro-IL-1β maturation in response to NLRP3-activating particles [13, 14]. However, phagocytosis is
not required for NLRP3 inﬂammasome activation by extracellular ATP or bacterial toxins, and conversely,
phagocytosis does not always result in inﬂammasome activation.
One common property of the particles and agents that activate NLRP3 is their ability to induce
generation of reactive oxygen species (ROS). ROS are known to regulate various signaling pathways raising
the possibility of their involvement in NLRP3 activation. The majority of the evidence implicating ROS in
inﬂammasome activation, however, was based on the use of pharmacological inhibitors, which can have
unspeciﬁc effects. In fact, genetic studies using mice deﬁcient in phagocytic oxidases have failed to conﬁrm
the importance of ROS for NLRP3 activation [15, 16]. More recent evidence showed that the role of ROS on
NLRP3 inﬂammasome activation was at the level of the priming step, the requirement for NF-κB-mediated
transcriptional induction of pro-IL-1β and NLRP3 itself, rather than at the level of inﬂammasome assembly
and activation of caspase-1 [17].
One of the earliest identiﬁed events triggered by all NLRP3 activator is K+ efﬂux [18]. Prevention
of K+ efﬂux by supplementing the cell growth medium with 130mMKCl is reported to block NLRP3
inﬂammasome activation in response to all known NLRP3 activators including nonparticulated ones such as
extracellular ATP and the microbial toxins nigericin, maitotoxin, and gramicidin. These toxins allow ﬂuxes
of single-charged cations and cause a marked depletion of intracellular K+. An important yet unanswered
questionishowK+ concentrationregulatesNLRP3assemblyintoafunctionalinﬂammasome.Interestingly,
K+ efﬂuxwasshowntoregulatealsotheactivationoftheNLRC4andtheNLRP1binﬂammasomes[19–21].
One model has been proposed where lysosome destabilization would play a central role in NLRP3
activation [16]. According to this model, phagocytosis of crystals or particles that the cell is unprepared
to handle properly would damage the lysosome and lead to leakage of the protease cathepsin B into the
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cytosol leading to NLRP3 activation. The idea of lysosome destabilization as an inﬂammasome-triggering
mechanism is attractive, because it is consistent with the pathogenic mechanism of bacteria known to
activate the NLRP3 inﬂammasome. Most of these bacteria (see below), in fact, produce a variety of toxins
that open pores or damage the host cell and vacuole membrane. Activation of NLRP3 by inﬂuenza virus
depends on the M2 protein, which also forms ion channels in the vacuole membrane [22]. Various crystals
were also shown to cause lysosome destabilization and rupture of the lysosomal membrane. Therefore, it
appears that the disruption of cell membranes integrity may be a common event triggered by the NLRP3
activators, and in this sense, the NLRP3 inﬂammasome may be viewed as a guardian of membrane integrity.
Recent work has shown that silencing expression of the NLR molecule NLRC5 inhibits activation of the
NLRP3 inﬂammasome by bacteria, suggesting that NLRP3 may work in concert with NLRC5 [23].
The NLRC4 inﬂammasome is responsive to a narrower spectrum of activators, including
cytoplasmically delivered bacterial ﬂagellin [24–26] and the basal rod constituent of various bacterial Type
III secretion systems (T3SS) [27]. The T3SS apparatus and other analogous bacteria secretion systems
are used by several bacteria, including those of the genus Salmonella, Listeria, Francisella, Shigella, and
Legionella to inject virulence factors into the cytoplasm of target cells [28]. NLRC4 activation, at least in
some experimental settings, may occur independently of ASC, presumably because the CARD domain of
NLRC4 may directly interact with the CARD of caspase-1 [29–32]. Recent works [33, 34] demonstrate that
the speciﬁcity of the NLRC4 inﬂammasome for distinct bacterial ligands is determined by its pairing with
different members of the NAIP family, a subgroup of NLR molecules. Thus, NAIP5 allows the recognition
of bacterial ﬂagellin by NLRC4, while NAIP2 confers speciﬁcity for T3SS rod proteins such as Salmonella
PrgJ and Burkholderia BsaK.
The form of cell death induced by the NLRC4 inﬂammasome is termed pyroptosis, depends on
caspase-1, but occurs independently of the adaptor molecule ASC [7]. Another form of cell death, called
pyronecrosis, is induced by NLRP3 and, in contrast to pyroptosis, does not require caspase-1 [9]. As
the names suggest, both pyroptosis and pyronecrosis incite an inﬂammatory response that adds to the
inﬂammation initiated by the recognition of microbial products. Release of the endogenous danger signal
HMGB1 has been reported during pyronecrosis and pyroptosis [35].
AIM2 is a recently identiﬁed PYHIN protein that was shown to mediate innate immune responses to
cytosolic DNA [36–38]. AIM2 binds cytosolic double-stranded DNA derived from a variety of pathogens
including bacteria and viruses through its single HIN domain and through its PYD domain promotes the
assembly of an ASC-containing inﬂammasome. Recently published work has identiﬁed another PYHIN
family members, IFI16, that can form an inﬂammasome capable of activating caspase-1 in response to viral
infection [39]. Interestingly, IFI16 is reported to recognize the viral genome in the cell nucleus, the ﬁrst
example of a nuclear inﬂammasome. IFI16 is also unique in that it contains two HIN domains. One major
unanswered question regarding the AIM2 inﬂammasome is how the bacterial DNA reaches the cytoplasm
and is made available for interaction with AIM2.
2. ROLE OF IL-1β AND IL-18 IN BACTERIAL INFECTIONS
A great number of publications have documented the role of IL-18 and IL-1β during infections with a
variety of pathogens. Almost invariably, both cytokines were found to have a protective function [40, 41].
One of the main functions of IL-18 is to promote the production of IFNγ from T and NK cells,
particularly in the presence of IL-12p70. IL-18 also promotes the secretion of other proinﬂammatory
cytokines like TNFα,I L - 1 β, IL-8, and GM-CSF and, as a consequence, enhances expansion, migration, and
activation of neutrophils during infections. In addition, IL-18 enhances cytotoxic activity and proliferation
of CD8+ T and NK cells. The protective role of IL-18 during bacterial infections is primarily related to its
ability to induce IFNγ, a cytokine that activates the microbicidal activity of macrophages through induction
of nitric oxide production.
IL-1β has been shown to be protective in several bacterial, viral, and fungal infection models. Studies
in humans have also shown that the inhibition of the function of IL-1 using the IL-1R antagonist IL-1ra
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(Kineret) is associated with increased susceptibility to bacterial infection. IL-1β is one of the most powerful
proinﬂammatory cytokines; it affects virtually every organ, and several human pathologies are primarily
driven by unrestrained IL-1β production. IL-1β exerts its protective action against infections by activating
several responses including the rapid recruitment of neutrophils to inﬂammatory sites, activation of the
endothelial adhesion molecules, induction of cytokines and chemokines, induction of the febrile response,
and the stimulation of speciﬁc type of adaptive immunity like the Th17 response.
The inﬂammatory response to infection consists of several protective effector mechanisms that
must be activated and orchestrated in order to maximize microbicidal functions and the stimulation of
adaptive immunity while, at the same time, minimize damage to the host tissues. Alteration in this balance
may result in excessive and nonresolving inﬂammation that is cause of severe morbidity and mortality
[42]. Excessive inﬂammation, in fact, has been shown to be detrimental in certain infection models. For
example, TLR-mediated signaling negatively affects the outcome of infections with West Nile virus [43]
or inﬂuenza virus [44]. Excessive PMN recruitment is known to cause tissue damage leading to functional
impairment of multiple organs, particularly the lungs [45]. Among the proinﬂammatory cytokines, IL-1β
has one of the highest potential of to cause damage to the host tissues, and in fact, various mechanisms
are devoted to restrain its activity, intracellularly, by carefully controlling its transcription and processing
by the inﬂammasome and, extracellularly, by inhibition of its receptor signaling through the IL-1ra and the
type II decoy receptor. Considering the potential to harm the host, it is not surprising that in some animal
infection models, IL-1β and IL-18 were shown to be detrimental. Both cytokines were reported to have a
negativeeffectonbacterialclearanceinamodelofpneumoniacausedbyPseudomonasaeruginosa[46,47].
Similarly, it has been reported that IL-18 has a detrimental role in a murine model of ehrlichiosis caused
by the intracellular bacterium Ixodes ovatus ehrlichia [48]. Our recent study also showed that because of
excessive recruitment of neutrophils, IL-1β is deleterious in a mouse model of melioidosis caused by B.
pseudomallei (see below).
As the examples brieﬂy mentioned in this paper will indicate, a common theme that emerges from the
analysis of the literature regarding the host-pathogen interactions is the notion that in order to be effective
but nonpathogenic the inﬂammatory response must be tailored to each speciﬁc pathogen. Thus, production
of IL-18 or IL-1β may be protective during certain infections but deleterious for other, pyroptosis effective
against some pathogens but not other.
3. ROLE OF INFLAMMASOME IN BACTERIAL INFECTION
Both effector mechanisms activated by the inﬂammasome (production of IL-1β and IL-18 and induction of
pyroptosis and pyronecrosis) have been shown to be protective against many infectious agents. It is worth
to emphasize that although inﬂammasome activation has been documented in response to infection with a
large number of bacteria in vitro, it has proven more difﬁcult to unequivocally determine the role of each
inﬂammasome and effector mechanisms for the ability of animals to survive the infection. This fact likely
reﬂects the redundancy of the pathways that lead to inﬂammasome activation during bacterial infection.
As reviewed below, several bacteria species can activate multiple inﬂammasome pathways that converge
on caspase-1 activation. Thus, deﬁciency of caspase-1 or IL-1β/IL-18 commonly results in a more severe
phenotype than deﬁciency in speciﬁc NLR or PYHIN proteins. Moreover, with a few notable exceptions, it
has proven difﬁcult to determine the relative contribution of IL-1β, IL-18, and pyroptosis to the ability to
survive infection, because these responses are coregulated and, therefore, difﬁcult to analyze separately.
3.1. Salmonella typhimurium
Salmonella enterica serovar Typhimurium (S.t.) is a Gram-negative bacterium that causes a systemic
typhoid-like disease and serves as an experimental model for human typhoid. S.t. infects intestinal epithelial
cells and macrophages and is able to survive inside the cells in a specialized vacuole. From here, the
bacterium injects various virulence factors into the host cell cytoplasm using T3SS, a common strategy used
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by many bacterial pathogens. The seminal report by Mariathasan et al. [29] showed that IL-1β secretion and
pyroptosis triggered by infection of macrophages with S.t. was dependent on NLRC4, ASC, and caspase-
1. Later, it was shown [49, 50] that NLRP3 was dispensable for those responses. Surprisingly, although
Casp1−/− mice are more susceptible to infection with S.t. than WT mice, Nlrp3−/−, Nlrc4−/−,o rAsc−/−
mice are not [51, 52], suggesting that multiple pathways may lead to caspase-1 activation in response to
S.t. infection. A recent paper by Broz et al. [53], in fact, showed that NLRC4 and NLRP3 are redundant
for inﬂammasome activation during S.t. infection and that mice deﬁcient in both NLRP3 and NLRC4
have higher bacterial burdens in organs than the single knockout mice. It is unclear whether the different
bacterial load observed in that study between single and double knockout translated into signiﬁcantly
different survival of the infected mice. A recent paper by Miao et al. [8] employed elegant genetic
manipulation to show that as S.t. strain that constitutively expresses ﬂagellin has attenuated virulence. In
the early phase of the infection, S.t. relies on the SPI1 T3SS to infect intestinal epithelial cells and inject
virulence factors, including ﬂagellin and the PrgJ rod protein, both of which are detected by the NLRC4
inﬂammasome. However, during infection of macrophages and systemic dissemination, S.t. manages to
elude inﬂammasome detection by silencing SPI1 and turning on SPI2, a different T3SS that does not
activate the inﬂammasome. The increased clearance of the ﬂagellin-expressing transgenic S.t. was due to the
activation of the NLRC4 inﬂammasome and induction of pyroptosis but was independent of the production
of IL-1β and IL-18. This is one of the ﬁrst reports to convincingly show the importance and effectiveness
of pyroptosis for restriction of bacteria in vivo. This study also indicates that evasion of NLRC4-mediated
detection can be a very powerful virulence strategy.
3.2. Listeria monocytogenes
Listeria monocytogenes (L.m.) is an intracellular, Gram-positive bacterium that can cause listeriosis, a
potentially lethal food-borne infection. L.m. infects many cell type including intestinal epithelial cells and
macrophages. The phagocytosed bacterium produces the listeriolysin O toxin that breaches the vacuolar
membrane allowing the bacterium to escape the phagosome and colonize the cytoplasm. Caspase-1
activation and IL-1β secretion by macrophages infected with L.m. was ﬁrst reported to be dependent on
NLRP3 and ASC [49]. More recently, several groups demonstrated that the NLRP3, NLRC4, and AIM2
inﬂammasomes contribute to caspase-1 activation, pyroptosis, and the secretion of IL-1β and IL-18 during
L.m. infection [54–57]. Thus, as is the case for other intracellular bacteria, different stages of the infection
process can be detected by distinct inﬂammasomes. This level of redundancy explains the observation that
Casp1−/− mice are more susceptible to infection than WT mice, yet no signiﬁcant difference in animal
survivalhasbeenreportedformicedeﬁcientintheotherinﬂammasomecomponentsNLRP3,ASC,NLRC4,
and AIM2. IL-18 has been shown to be protective during infection with L.m. [58], while IL-1β, although
protective in some studies, seems to play a less important role [59].
3.3. Legionella pneumophila
Legionella pneumophila (L.p.) is a motile Gram-negative bacterium that causes the Legionnaires’ disease, a
severe form of pneumonia. L.p. infects macrophages and is able to survive inside an intracellular specialized
vacuole. Through a Type IV secretion apparatus, L.p. injects virulence factors into the host cytoplasm.
Infection of macrophages with L.p. induces caspase-1 activation and the release of IL-1β, IL-18, and
pyroptosis [26, 32, 60–62]. Inﬂammasome activation requires the Type IV secretion system and the ﬂagellin
and is mediated by NLRC4. The adaptor ASC is required for IL-1β and IL-18 secretion but not pyroptosis.
Nlrc4−/−, Casp1−/−,o rIl-1b−/−/Il-18−/− mice infected with L.p. have higher bacterial burdens than
WT mice, while ASC seems to be dispensable for bacteria restriction in vivo [32, 62]. Flagellin-deﬁcient
L.p. is more virulent than the WT bacterium [61, 62], conﬁrming the effectiveness of inﬂammasome-
mediated responses at restricting bacteria growth. It has been demonstrated that activation of the NLRC4
inﬂammasome by Legionella ﬂagellin is also dependent on the Naip5 molecule, an NLR member that may
directly interact with NLRC4 [60, 61, 63].
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3.4. Shigella ﬂexneri
The Gram-negative bacteria Shigella ﬂexneri (S.f.) is the causative agent of bacillary dysentery. Activation
of caspase-1 and IL-1β secretion by macrophages infected with S.f. are mediated by the NLRC4
inﬂammasome [30]. Although S.f. does not possess a ﬂagellum, it has been showed that the basal rod
proteins that constitute the T3SS of this bacterium can be detected by the NLRC4 inﬂammasome [27].
S.f. infection of macrophages also triggers cell death by pyronecrosis in a NLRP3- and ASC-dependent
but caspase-1-independent fashion [9]. Caspase-1- and IL-18-deﬁcient mice are more susceptible to S.f.
infection, while Il-1b−/− have susceptibility similar to WT mice [64].
3.5. Pseudomonas aeruginosa
Pseudomonas aeruginosa (P.a.) is a Gram-negative ﬂagellate bacterium that causes opportunistic infections
in immunocompromised individuals. P.a. employs different T3SS to inject virulence factors into the
cytoplasm of host cells. Caspase-1 activation, IL-1β secretion, and pyroptosis during P.a. infection of
macrophages were shown to be dependent on the NLRC4 inﬂammasome [65, 66]. P.a. ﬂagellin transfected
into the cytoplasm was shown to activate the NLRC4 inﬂammasome [31] though P.a. ﬂagellin mutants were
also able to activate the NLRC4 inﬂammasome. This is consistent with the demonstrated ability of NLRC4
to recognize the basal rod components of the P.a.T3SS [27]. Nlrc4−/− mice infected with P.a. had higher
bacterial burdens than WT mice though the survival was not different [31]. In contrast, it was demonstrated
that IL-1β and IL-18 had a negative effect on bacterial clearance in a model of pneumonia caused by P.a.
[46, 47]. These results, thus, would suggest that the protective role of the inﬂammasome during pneumonia
caused by P.a. is mediated by pyroptosis and is independent of production of IL-1β and IL-18, a scenario
that is reminiscent of our observation regarding the infection with Burkholderia pseudomallei bacterium
(see below).
3.6. Francisella tularensis
Francisella tularensis (F.t.) is a Gram-negative bacterium that causes tularemia. F.t. infects macrophages
and epithelial cells and is able to evade the phagosome and invade and replicate in the host cell cytoplasm.
F.t. infection of macrophages leads to caspase-1 activation, pyroptosis, and the secretion of IL-1β and IL-
18 [67]. These responses were reported to require phagosome escape and ASC but not NLRC4 or NLRP3.
Recent works [54, 68, 69] have shown that inﬂammasome activation by F.t. is mediated by the AIM2
inﬂammasome that detects F.t. DNA in the cytoplasm. The role of IL-1β and IL-18 in the control of F.t.
infection in vivo has not been examined in detail. Administration of IL-1β and IL-18 neutralizing antibodies
increased bacterial burdens in organs though not as much as absence of caspase-1 [67]. Our unpublished
work indicates that IL-18 plays a prominent role in the early phase of the infection, while the role of IL-1β
becomes more important in the later stages of the infection possibly because of the requirement of IL-1β
for development of adaptive immunity against F.t.
3.7. Burkholderia pseudomallei
Burkholderia pseudomallei (B.p.), the etiologic agent of melioidosis, is a Gram-negative ﬂagellated
bacterium that infects macrophages and other cell types. B.p. infection was shown to result in caspase-1
activation, pyroptosis, and the secretion of IL-1β and IL-18 [70]. We have recently shown (Ceballos-Olvera
et al., manuscript submitted) that NLRP3 and NLRC4 differentially regulate pyroptosis and production of
IL-1β and IL-18 and are critical for resistance to melioidosis. In vitro production of IL-1β and IL-18 by
BMDC infected with B.p. was dependent on NLRC4 and NLRP3, while pyroptosis required only NLRC4.
Mice deﬁcient in the inﬂammasome components ASC, caspase-1, NLRC4, and NLRP3 were dramatically
more susceptible to lung infection with B.p. than WT mice. The heightened susceptibility of Nlrp3−/− mice
was due to decreased production of IL-18 and IL-1β. In contrast, the high susceptibility of Nlrc4−/− mice
2043TheScientiﬁcWorldJOURNAL (2011) 11, 2037–2050
was not due to lack of IL-1β and IL-18, which, in fact, were produced in higher amount than WT mice,
but rather to decreased pyroptosis and consequently higher bacterial burdens. Analyses of IL-18-deﬁcient
mice infected with B.p. revealed that IL-18 is essential for survival primarily because of its ability to induce
IFNγ production. In contrast, studies using IL-1RI-deﬁcient mice or WT mice treated with either IL-1β or
IL-1 receptor agonist revealed that IL-1β can have deleterious effects during melioidosis. The detrimental
role of IL-1β appeared to be due, in part, to excessive recruitment to the lung of neutrophils, cells that
are permissive to B.p. intracellular growth, because they do not express NLRC4 and, therefore, fail to
undergo pyroptosis. Thus, the NLRP3 and NLRC4 inﬂammasomes have nonredundant protective roles
in melioidosis: NLRC4 regulates pyroptosis, while NLRP3 regulates production of protective IL-18 and
deleterious IL-1β.
3.8. Mycobacteruim tubeculosis
Secretion IL-1β and IL-18 by macrophages infected with Mycobacteruim tubeculosis (Mtb) was reported
to be dependent on NLRP3 and ASC but not NLRC4 [71]. The mycobacterial secretion system ESX-1 was
required for the inﬂammasome activation [72]. Il-1r1−/− and Il-18−/− mice are very susceptible to Mtb
infection [73–75]. Casp1−/− and Asc−/− mice are also more susceptible than WT mice due to defective
granuloma formation [76]. However, the resistance of Nlrp3−/− mice to Mtb infection is not signiﬁcantly
different from that of WT mice, suggesting the existence of other pathways for inﬂammasome activation
during Mtb infection. Surprisingly, the production of IL-1β during Mtb infection was reported to occur also
in a caspase-1-independent fashion [77].
3.9. Staphylococcus aureus
Activation of the inﬂammasome by Staphylococcus aureus (S.a.) was reported to be dependent on NLRP3
and ASC [78, 79]. Inﬂammasome activation by S.a. required the alpha, beta, and gamma hemolysins [78,
79]. It has been shown that phagocytosis of the particulate peptidoglycan from the bacterial cell wall can
trigger secretion of IL-1β. Interestingly, S.a. can modify its cell wall peptidoglycan to avoid recognition
by NLRP3 inﬂammasome [80]. IL-1β production is important for neutrophil recruitment and bacterial
clearance during S.a. infection in vivo [81].
3.10. Streptococcus Group
Activation of NLRP3 inﬂammasome and IL-1β secretion by Streptococcus pneumoniae (S.p.) requires the
bacterial toxin pneumolysin [82]. IL-18 was shown to provide protection from S. pneumoniae and Group B
Streptococci infection through its ability to induce IFNγ.[ 83, 84]. Similarly to S.p., S. pyogenes produces a
pore-formingtoxin,streptolysinO,whichactivatescaspase-1viaNLRP3inﬂammasome,andASCresulting
in secretion of IL-1β.[ 85]. In addition, it has also been reported that NLRC4 senses Group A Streptococci
associate with Beclin1 and negatively regulates maturation of autophagosome and endosome [86].
3.11. Bacillus anthracis
The lethal toxin (LT) of B. anthracis was shown to activate the NLRP1 inﬂammasome in mouse
macrophages resulting in IL-1β secretion [87–89]. Anthrax spores were also shown to induce pyroptosis
of infected macrophages, which was originally proposed to be a protective mechanism in an in vivo
infection model [89]. Activation of the NLRP1b inﬂammasome by LT involves lysosomal membrane
permeabilization and may lead to cathepsin B release into in the cytosol [90], suggesting that activation
of the NLRP1 and NLRP3 inﬂammasomes may share common mechanistic aspects.
3.12. Other Bacteria
Several other bacteria have been shown to activate the NLRP3 inﬂammasome resulting in IL-1β
secretion and caspase-1-dependent pyroptosis or caspase-1-independent pyronecrosis. In several cases, the
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inﬂammasome activation is due to the action of toxins that disrupt cell membrane such as the aerolysin
of Aeromonas hydrophila [91] or the hemolysis of Vibrio species [92]. Infection with Neisseria gonorea
[93]a n dKlebsiella pleumoniae [94] activates NLRP3 and induces pyronecrosis and release of HMGB1.
Chlamyidia species that reside in a modiﬁed vacuole inside the cell also activate NLRP3 [95, 96]. Activation
of both NLRC4 and NLRP3 inﬂammasomes by Yersinia pestis depends on the T3SS and is antagonized by
YopK, a bacterial virulence factor that is injected into the host cell cytoplasm [97].
4. CONCLUSIONS
The discovery of the inﬂammasome and the PRR that constitutes it has spurred a resurgence in the interest in
“old” cytokines like IL-1β and IL-18 as well as interests into new forms of cell death. The challenge for the
future will be to determine the role played by each inﬂammasome effector mechanisms in the pathogenesis
of infectious diseases and other inﬂammatory pathologies and to conceive novel clinical interventions to
selectively block the deleterious responses and boost the protective ones.
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